Compugen licenses Selexis’ Cell line-Based Protein Expression Platform
Global life sciences company and a global leader in mammalian cell line generation technology, Selexis SA asserted that Compugen has obtained license to the Selexis SUREtechnology …
Read More...
Read More...
